India approaches Egypt, UAE, Uzbekistan, Bangladesh for Remdesivir
Faced with an acute shortage of the antiviral drug, India had earlier this month waived import duty on import of Remdesivir and the raw materials used to manufacture it. Official sources here described as a diplomatic victory Remdesivir owner Gilead's decision to donate 450 vials of the drug and also provide raw materials for ramping up local production.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Bangladesh Health | Biotechnology | Egypt Health | India Health | Pharmaceuticals | Uzbekistan Health